Aadi Bioscience, Inc. (AADI)
NASDAQ: AADI · IEX Real-Time Price · USD
13.43
+0.66 (5.17%)
Jul 5, 2022 4:00 PM EDT - Market closed
Balance Sheet (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
---|---|---|---|---|---|---|---|
Cash & Equivalents
|
148.99 | 4.46 | 38.56 | 62.65 | 20.29 | 1.63 | 0.02 |
Short-Term Investments
|
0 | 0 | 0 | 0 | 0 | 0.05 | 0 |
Cash & Cash Equivalents
|
148.99 | 4.46 | 38.56 | 62.65 | 20.29 | 1.68 | 0.02 |
Cash Growth
|
3244.31% | -88.45% | -38.45% | 208.87% | 1106.97% | 8970.40% | - |
Receivables
|
0 | 14.15 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
|
2.28 | 0.08 | 1.01 | 1.33 | 0.61 | 0.54 | 0 |
Total Current Assets
|
151.27 | 18.69 | 39.57 | 63.98 | 20.9 | 2.23 | 0.02 |
Property, Plant & Equipment
|
0.61 | 0.14 | 0.33 | 0.1 | 0.11 | 0.15 | 0 |
Goodwill and Intangibles
|
3.81 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Long-Term Assets
|
2.21 | 0 | 0.04 | 0.04 | 0.02 | 0.02 | - |
Total Long-Term Assets
|
6.64 | 0.14 | 0.37 | 0.14 | 0.13 | 0.17 | 0 |
Total Assets
|
157.91 | 18.83 | 39.94 | 64.12 | 21.03 | 2.4 | 0.02 |
Accounts Payable
|
12.2 | 16.71 | 3.23 | 5.46 | 3.59 | 2.47 | 0 |
Current Debt
|
0.13 | 9.15 | 0.1 | 0 | 0 | 12.39 | 0.16 |
Other Current Liabilities
|
2.95 | 4.2 | 0 | 0 | 0 | 0 | 0.04 |
Total Current Liabilities
|
15.27 | 30.06 | 3.33 | 5.46 | 3.59 | 14.86 | 0.21 |
Long-Term Debt
|
0.47 | 1.1 | 0.07 | 0 | 0 | 0 | 0 |
Other Long-Term Liabilities
|
5.76 | 0.1 | 0 | - | - | 73.76 | - |
Total Long-Term Liabilities
|
6.23 | 1.2 | 0.07 | 0 | 0 | 73.76 | 0 |
Total Liabilities
|
21.5 | 31.26 | 3.4 | 5.46 | 3.59 | 88.62 | 0.21 |
Total Debt
|
0.61 | 10.26 | 0.17 | 0 | 0 | 12.39 | 0.16 |
Debt Growth
|
-94.10% | 5933.19% | - | - | - | 7641.65% | - |
Common Stock
|
279.09 | 20.16 | 178.77 | 177.63 | 126 | 0 | 0.05 |
Retained Earnings
|
-142.69 | -32.6 | -142.24 | -118.96 | -108.56 | -86.22 | -0.24 |
Shareholders' Equity
|
136.41 | -12.43 | 36.54 | 58.67 | 17.44 | -86.22 | -0.19 |
Total Liabilities and Equity
|
157.91 | 18.83 | 39.94 | 64.12 | 21.03 | 2.4 | 0.02 |
Net Cash / Debt
|
148.38 | -5.8 | 38.39 | 62.65 | 20.29 | -10.71 | -0.14 |
Net Cash / Debt Growth
|
- | - | -38.72% | 208.87% | - | - | - |
Net Cash Per Share
|
16.63 | -2.28 | 14.19 | 27.70 | 14.04 | -188.34 | -0.42 |
Working Capital
|
136 | -11.37 | 36.24 | 58.53 | 17.31 | -12.63 | -0.19 |
Book Value Per Share
|
15.29 | -4.89 | 13.50 | 25.93 | 12.07 | -1.00 | -0.56 |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).